Meinian Onehealth - Public Comps and Valuation Multiples

Meinian Onehealth Overview

About Meinian Onehealth

Meinian Onehealth Healthcare Holdings Co Ltd is engaged in the provision of physical examination and medical services. The firm provides health consultation, and health assessment services among others.

Founded

2004

HQ

Employees

2.1K+

Website

health-100.cn

Sectors

Hospitals & Clinics

Financials

LTM Revenue $1.6B

LTM EBITDA $282M

EV

$3.4B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Meinian Onehealth Financials

As of September 2025, Meinian Onehealth reported last 12-month revenue of $1.6B and EBITDA of $282M.

In the same period, Meinian Onehealth generated $664M in LTM gross profit and $63.9M in net income.

See Meinian Onehealth valuation multiples based on analyst estimates

Meinian Onehealth P&L

In the most recent fiscal year, Meinian Onehealth reported revenue of $1.5B and EBITDA of $280M.

Meinian Onehealth expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Meinian Onehealth valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$1.6B	XXX	$1.5B	XXX	XXX	XXX
Gross Profit	$664M	XXX	$642M	XXX	XXX	XXX
Gross Margin	42%	XXX	43%	XXX	XXX	XXX
EBITDA	$282M	XXX	$280M	XXX	XXX	XXX
EBITDA Margin	18%	XXX	19%	XXX	XXX	XXX
EBIT	$114M	XXX	$155M	XXX	XXX	XXX
EBIT Margin	7%	XXX	10%	XXX	XXX	XXX
Net Profit	$63.9M	XXX	$39.6M	XXX	XXX	XXX
Net Margin	4%	XXX	3%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Meinian Onehealth including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.6B. EBITDA for the last twelve months was $282M. In the most recent fiscal year, Meinian Onehealth achieved $1.5B in revenue and $280M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$1.6B	Analyst estimates available to subscribers	$1.5B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$664M	Analyst estimates available to subscribers	$642M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	42.4% gross margin	Analyst estimates available to subscribers	42.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$282M	Analyst estimates available to subscribers	$280M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	18.0% EBITDA margin	Analyst estimates available to subscribers	18.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$114M	Analyst estimates available to subscribers	$155M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	7.3% EBIT margin	Analyst estimates available to subscribers	10.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$63.9M	Analyst estimates available to subscribers	$39.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	4.1% net profit margin	Analyst estimates available to subscribers	2.6% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Meinian Onehealth

This financial data table provides comprehensive performance metrics for Meinian Onehealth, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Meinian Onehealth generated $1.6B in revenue over the last twelve months.
The company achieved $282M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $664M.
Net income over the last twelve months reached $63.9M.

Fiscal Year Performance

In the most recent fiscal year, Meinian Onehealth reported $1.5B in total revenue.
Fiscal year EBITDA was $280M.
The company maintained a gross profit margin of 42.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 18.6%.
Net profit margin reached 2.6% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Meinian Onehealth. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Meinian Onehealth Stock Performance

Meinian Onehealth has current market cap of CNY 19.9B (or $2.8B), and EV of CNY 24.2B (or $3.4B).

Market Cap Evolution

Meinian Onehealth Stock Data

As of October 17, 2025, Meinian Onehealth's stock price is CNY 5 (or $1).

See Meinian Onehealth trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.4B	$2.8B	XXX	XXX	XXX	XXX	$0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Meinian Onehealth Valuation Multiples

Meinian Onehealth's trades at 2.3x EV/Revenue multiple, and 12.1x EV/EBITDA.

See valuation multiples for Meinian Onehealth and 15K+ public comps

Meinian Onehealth Financial Valuation Multiples

As of October 17, 2025, Meinian Onehealth has market cap of $2.8B and EV of $3.4B.

Equity research analysts estimate Meinian Onehealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Meinian Onehealth has a P/E ratio of 43.7x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$2.8B	XXX	$2.8B	XXX	XXX	XXX
EV (current)	$3.4B	XXX	$3.4B	XXX	XXX	XXX
EV/Revenue	2.2x	XXX	2.3x	XXX	XXX	XXX
EV/EBITDA	12.0x	XXX	12.1x	XXX	XXX	XXX
EV/EBIT	29.8x	XXX	21.8x	XXX	XXX	XXX
EV/Gross Profit	5.1x	XXX	n/a	XXX	XXX	XXX
P/E	43.7x	XXX	70.6x	XXX	XXX	XXX
EV/FCF	n/a	XXX	19.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Meinian Onehealth Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Meinian Onehealth Margins & Growth Rates

Meinian Onehealth's last 12 month revenue growth is 10%

Meinian Onehealth's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.2M for the same period.

Meinian Onehealth's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Meinian Onehealth's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Meinian Onehealth and other 15K+ public comps

Meinian Onehealth Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	10%	XXX	8%	XXX	XXX	XXX
EBITDA Margin	18%	XXX	19%	XXX	XXX	XXX
EBITDA Growth	15%	XXX	-5%	XXX	XXX	XXX
Rule of 40	30%	XXX	29%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	43%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.7M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	6%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	32%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial